Full View

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, R L. Castelino… - … Advances in Drug …, 2024 - journals.sagepub.com
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …
相关文章

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino, SC Inglis… - 2024 - dro.deakin.edu.au
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino… - … Advances in Drug …, 2024 - pure.johnshopkins.edu
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …
[HTML] nih.gov

[HTML][HTML] Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort …

F Shaikh, R Wynne, RL Castelino… - … Advances in Drug …, 2024 - ncbi.nlm.nih.gov
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino, SC Inglis… - … Advances in Drug …, 2024 - ro.uow.edu.au
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino… - … advances in drug …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study.

F Shaikh, R Wynne, SC Inglis, PM Davidson… - … Advances in Drug …, 2024 - europepmc.org
Background Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino, SC Inglis… - 2024 - wslhd.intersearch.com.au
BACKGROUND: Atrial fibrillation (AF) and obesity are common conditions globally; yet,
there remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino, SC Inglis… - 2024 - europepmc.org
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

F Shaikh, R Wynne, RL Castelino, SC Inglis… - 2024 - dro.deakin.edu.au
Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …